Giuseppe Favacchio
Via Manzoni 56
Milan, 20089, Italy
Milan, 20089, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Real-world sex differences in type 2 diabetes patients treated with GLP-1 receptor agonists.
Journal: Diabetes research and clinical practice
Published: January 31, 2024
Pathophysiological basis of the cardiological benefits of SGLT-2 inhibitors: a narrative review.
Journal: Cardiovascular diabetology
Published: February 23, 2023
Time-dependent effect of GLP-1 receptor agonists on cardiovascular benefits: a real-world study.
Journal: Cardiovascular diabetology
Published: January 13, 2023
Real world effectiveness of subcutaneous semaglutide in type 2 diabetes: A retrospective, cohort study (Sema-MiDiab01).
Journal: Frontiers in endocrinology
Published: November 15, 2022
SGLT2-inhibitors are effective and safe in the elderly: The SOLD study.
Journal: Pharmacological research
Published: June 13, 2022
Biochemical Efficacy of Sodium-Glucose Cotransporter 2 Inhibitors by Cardiovascular Risk Profile and Volume Status in a Real-World Diabetic Population.
Journal: Journal of cardiovascular pharmacology
Published: December 08, 2021
Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study.
Journal: Endocrine
Published: March 01, 2021
Vitamin D deficiency, secondary hyperparathyroidism and respiratory insufficiency in hospitalized patients with COVID-19.
Journal: Journal of endocrinological investigation
Published: January 04, 2021
Liraglutide and cardiovascular outcomes in a real world type 2 diabetes cohort.
Journal: Pharmacological research
Published: June 15, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026